North America Aptamers Market by type - (Peptide aptamers, Nucleic Acid aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), by Application - (Therapeutics Development, Diagnostics, Research and Development), by End users - (Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

North America Aptamers Market by type - (Peptide aptamers, Nucleic Acid aptamers (DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers)), by Application - (Therapeutics Development, Diagnostics, Research and Development), by End users - (Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1135 | Pages: 135 | November 2016 | Region: North America


The North America Aptamers Market was worth $ 48.03 Million in 2016 and estimated to reach $ 103.07 Million by the end of 2021 with a growing potential of 16.50 %.  Aptamers are oligonucleotides that bind to target protein, lipid, or nucleic acid molecules with a high specificity.

The enormous opportunities offered by the market for the key players are the drug discovery, biomarker discovery, and diagnostics segments. The launch of Macugen, the first aptamer drug and the first diagnostic test for testing mycotoxins in grains has recognised the potential of aptamers in diagnostics and therapeutics. So, the market for aptamers is expected to grow, backed by technological advancements with respect to selection processes and synthesis.

The North America market is driven by advancement in technology, availability of R&D investments in pharmaceutical and biotechnology industries, low cost and high efficacy in binding to large molecules compared to antibodies. Ethical issues for some aptamers, Stringent regulations in use of aptamers, slow in reaching the market place due to regulatory hurdles may hinder the growth of the market.   

The North America Aptamers Market is broadly categorized by type into Peptide aptamers, Nucleic Acid aptamers. Nucleic Acid aptamers are further categorized into DNA-Based Aptamers, RNA-Based Aptamers, and XNA-Based Aptamers.

Based on Application the market is categorized into Therapeutics Development, Diagnostics, Research and Development and on the basis of end users the market is segmented into Pharmaceutical Companies, Bio-Pharmaceutical companies, Academic and Research Centres and on the basis of geography, the North America Aptamers market is analysed under various regions namely U.S, Canada.

Some of the major companies influencing the North America Aptamers market are AM Biotechnologies, Aptagen, Aptamer Sciences Inc., Aptamer Solutions Ltd., Aptus Biotech S.L., Base Pair Biotechnologies Inc., NeoVentures Biotechnology Inc., SomaLogic Inc, TriLink BioTechnologies Inc., and Vivonics, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 Peptide Aptamers

                                5.1.2 Nucleic Acid Aptamers       

                                                5.1.2.1 DNA-Based Aptamers

                                                5.1.2.2 RNA-Based Aptamers

                                                5.1.2.3 XNA-Based Aptamers

                5.2 By Application                           

                                5.2.1 Therapeutics Development             

                                5.2.2 Diagnostics             

                                5.2.3 Research and Developments          

                5.3 By End Users                             

                                5.3.1 Pharmaceutical Companies             

                                5.3.2 Bio-Pharmaceutical Companies     

                                5.3.3 Academic and Research Centers    

6. Geographical Analysis                                              

                                6.1 Introduction              

                                6.2 United States            

                                6.3 Canada         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 AM Biotechnologies               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Aptagen                      

                8.3 Aptamer Sciences Inc.                            

                8.4 Aptamer Solutions Ltd                           

                8.5 Aptus Biotech S.L.                    

                8.6 Base Pair Biotechnologies Inc                             

                8.7 NeoVentures Biotechnology Inc.                       

                8.8 SomaLogic Inc                           

                8.9 TriLink BioTechnologies Inc                  

                8.10 Vivonics, Inc                            

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Aptamers Market By Type, From 2016-2021 ( USD Billion )
  2. North America Peptide Aptamers Market By Region, From 2016-2021 ( USD Billion )
  3. North America Nucleic Acid Aptamers Market By Region, From 2016-2021 ( USD Billion )
  4. North America Aptamers Market By Application, From 2016-2021 ( USD Billion )
  5. North America Therapeutics Development Market By Region, From 2016-2021 ( USD Billion )
  6. North America Diagnostics Market By Region, From 2016-2021 ( USD Billion )
  7. North America Research and Development Market By Region, From 2016-2021 ( USD Billion )
  8. North America Aptamers Market By End users, From 2016-2021 ( USD Billion )
  9. North America Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Billion )
  10. North America Bio-Pharmaceutical Companies Market By Region, From 2016-2021 ( USD Billion )
  11. North America Academic and Rsearch centers Market By Region, From 2016-2021 ( USD Billion )
  12. United States Aptamers Market By Type, From 2016-2021 ( USD Billion )
  13. United States Aptamers Market By Application, From 2016-2021 ( USD Billion )
  14. United States Aptamers Market By End users, From 2016-2021 ( USD Billion )
  15. Canada Aptamers Market By Type, From 2016-2021 ( USD Billion )
  16. Canada Aptamers Market By Application, From 2016-2021 ( USD Billion )
  17. Canada Aptamers Market By End users, From 2016-2021 ( USD Billion )
  18. North America Aptamers Market By Nucleic Acid Aptamers, From 2016-2021 ( USD Billion )
  19. North America DNA Based Aptamers Market By Region, From 2016-2021 ( USD Billion )
  20. North America RNA Based Aptamers Market By Region, From 2016-2021 ( USD Billion )
  21. North America XNA Based Aptamers Market By Region, From 2016-2021 ( USD Billion )
  22. United States Aptamers Market By Nucleic Acid Aptamers, From 2016-2021 ( USD Billion )
  23. Canada Aptamers Market By Nucleic Acid Aptamers, From 2016-2021 ( USD Billion )

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.